Kinex Pharmaceuticals LLC is categorized under Biotechnology Products and Services in Buffalo, NY .
Kinex Pharmaceuticals LLC was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Johnson Y Lau, Chief Executive Officer at the company’s single location by writing to 1207 Delaware Avenue, Buffalo, New York NY 14209 or by phoning (716) 332-6107. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kinex Pharmaceuticals LLC |
| Contact Person: | Johnson Y Lau, Chief Executive Officer |
| Address: | 1207 Delaware Avenue, Buffalo, New York 14209 |
| Phone Number: | (716) 332-6107 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Kinex Pharmaceuticals LLC was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Johnson Y Lau, Chief Executive Officer for inquiries that concern Kinex Pharmaceuticals LLC by calling the company number (716) 332-6107, as your correspondence is most welcome. Additionally, the physical location of the single location of Kinex Pharmaceuticals LLC can be found at the coordinates 42.915633,-78.86541 as well as the street address 1207 Delaware Avenue in Buffalo, New York 14209.
For its online presence, you may visit Kinex Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.